Primary FDA-Approved Indications
Amoxicillin is widely used in pediatric practice for bacterial infections, otitis media, strep throat, pneumonia. It is FDA-approved for use in newborns and all pediatric ages with typical dosing of 20-90 mg/kg/day divided into 2-3 doses. Clinical evidence supports its safety and efficacy when used as directed.
Acute Otitis Media (Middle Ear Infection)
FDA ApprovedAmoxicillin remains the first-line antibiotic for most acute otitis media cases in children without recent amoxicillin exposure
Efficacy Data
Evidence Sources
Streptococcal Pharyngitis (Strep Throat)
FDA ApprovedRecommended as a first-line therapy (along with penicillin) for confirmed group A strep throat due to its narrow spectrum and safety
Efficacy Data
Evidence Sources
Acute Bacterial Sinusitis
FDA ApprovedAmoxicillin (alone or with clavulanate) remains first-line therapy for uncomplicated bacterial sinusitis in children